New approaches for successful islet transplantation

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 7, Issue 4, 2000, Pages 358-363

  Gotoh, Mitsukazu ^a   Sato, Yoshihiro ^a   Abe, Tsuyoshi ^a   Kanazawa, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti adhesion therapy; Bleb formation; CTLA4 Ig; FasL; Genotoxic stress; Islet immunogenicity; Islet transplantation; Jmmunoregulatory cells; Mitomycin C; Mul tiple donors; Petreatment of islets; Transfection

Indexed keywords

CYTOKINE; IMMUNOLOGICAL ADJUVANT; LYMPHOCYTE ANTIBODY; MITOMYCIN; MONOCLONAL ANTIBODY;

ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; PHYSIOLOGY; REVIEW; T LYMPHOCYTE; TESTIS; TRANSPLANTATION; XENOGRAFT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MITOMYCIN; T-LYMPHOCYTES; TESTIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034576179     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340070029     Document Type: Article

References (33)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. International Pancreas Transplant Registry (1999) Newsletter 11
3. International Islet Transplant Registry (1999) Newsletter 8, Draft
4. Lacy PE. Davic JM. Finke EH, Scharp DW (1979) Prolongation of islet allograft survival. Transplantation 27:171-174
5. Faustman DL. Hauptfeld V, Lacy P. Davie J (1981) Prolongation of rnurine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci USA 78:5156-5159
6. Lau H, Reemtsma K. Hardy MA (1984) Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft. Science 223:607-609
7. Gotoh M. Maki T. Satomi S. Porter J, Monaco AP (1986) Imtnunological characteristics of purified islet graft. Transplantation 42:387-390
8. Gotoh M, Maki T, Porter J, Monaco AP (1987) Augmented survival of purified islet xeno-and allografts with reduced numbers. Transplant Proc 19:984
9. Gotoh M. Porter J. Kanai T, Monaco AP. Maki T (1988) Multiple donor allotransplantation: a new approach to pancreatic islet transplantation. Transplantation 45:1008-1012
10. Kanai T. Gotoh M, Porter J, Monaco AP. Maki T (1988) Multiple-donor composite and sequential allografls: a new approach to pancreatic islet transplantation. Transplant Proc 20 [Suppl 1]:891-893
11. Gotoh M, Porter J. Monaco AP. Maki T (1988) Induction of antigen-specific unresponsiveness to pancreatic islet allopiafts by antilymphocyte serum. Transplantation 45:429-433
12. Rebellato LM, Gross U, Verbanac KM, Thomas JM (1994) A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 57: 685-694
13. Yamamoto H, Monden M, Kawai M. Uenaka A, Gotoh M. Mori T. Sakurai M. Shiku H. Nakayama E (1990) The role of CDS + and CD4+ cells in islet allograft rejection. Transplantation 50:120-125
14. Nishihara M, Gotoh M, Ohzato H, Ohta Y. Luo Z. Dimo K. umeshita K, Sakon M. Monden M, Yagita H. Okumura K. Miyasaka M (1997) Awareness of donor alloantigcns in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts. transplantation 64:965-970
15. Chavin KD. Lau HT. Bromberg JS (1992) Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation 54:286-291
16. Gotoh M, Fukuzaki T. Monden M. Dono K. Kanai T, Yagita H. Okumura K. Mori T (1994) A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation. Transplantation 57:123-126
17. Lensehow DJ. Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS. Bluestone JA (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257:789-792
18. Lensehow DJ. Zeng Y. Hathcock KS. Zuckerman LA. Freeman G. Thistlethwaite JR. Gray GS. Modes RJ. Bluestone JA (1995) Inhibition of transplant rejection following treatment with anii-B7-2 and anti-B7-l antibodies. Transplantation 60:1171-1178
19. Parker DC. Greiner DL, Phillips NE, Appel MC. Steele AW. Durie FH. Noelle RJ. Mordes JP, Rossini AA (1995) Survival of mouse pancreatic islet allografts in recipients treated with allosieneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 92:9560-9564
20. Luo Z., Gotoh M, Grochovviecki T, Tanaka T, Kimura F, Kawashima H, Yagita H. Okumura K. Miyasaka M (2000) Anergic cells generated in vitro suppress rejection response to islet nllografts. Transplantation 69:2144-2148
21. Isobe M, Yagita H, Okumura K, Ihara A (1992) Specific acceptance of cardiac allografl after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125-1127
22. Zeng Y. Gage A, Montag A, Rothlin R, Thistlethwaitc JR, Bluestone JA (1994) Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anli-ICAM-1 antibodies. Transplantation 58:681-689
23. Stepkowski SM, Wang ME. Condon TP, Cheng-Flournoy S. Sleeker K, Graham M, Qu X, Tian L, Chen W, Kahan BD, Bennett CF (1998) Protection against allograft rejection with intercellular adhesion molecule-1 antiscnse oligodeoxynucleotides. Transplantation 66:699-707
24. Tran HM, Nickerson PW, Restifo AC, Ivis-Woodward MA. Patel A. Alien RD, Strom TB. O'Connell PJ (1997) Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J Immunol 159:2232-2239
25. Miyazaki J, Araki K, Yamamolo E, Ikegami H, Asano T, Shibasaki Y, Oka Y. Yamamura Y (1990) Establishment of a pancreatic buta cell line that retains glucose-induciblc insulin se-cretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132
26. Bellgrau D. Gold D. Selawry H, Moore J, Franzusoff A. Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377:630-632
27. Takeda Y. Gotoh M. Dono K, Nishihara M, Grochowiecki T, Kimura F, Yoshida T, Ohta Y. Ota H. Ohzato H, Umeshita K, Takeda T. Matsuura N, Sakon M, Kayagaki N, Yagita H, Okumura K, Miyasaka M. Monden M (1998) Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Diabetologia 41:315-321
28. Allison J, Georgien MH, Strasser A. Vaux LD (1997) Transgenic expression of CD95 ligand on islet ßcells induces a granulocytic infiltration but docs not confer immune privilege upon islet allografts. Proc Natl Aead Sci USA 94: 3943-3947
29. Canman CE. Kastan MB (1996) Signal transduction. Three paths to stress relief. Nature 384:213-214
30. Grochowiecki T, Gotoh M, Dono K, Takeda Y, Nishihara M, Ohta Y, Ota H, Ohzato H, Okuyama M, Shimizu J, Kimura F, He L. Nagano H, Nkamori S, Umeshita K. Sakon M, Monden M (1999) Pretrcatment of crude pancreatic islets with mitomycin C prolongs graft survival time in xenogeneic-ral-to mouse model. Transplantation 67:1474-1477
31. Grochowiecki T. Gotoh M, Dono K. Takeda Y, Sakon M, Yagita H, Okumura K. Miyasaka M, Monden M. Induction of unrcspon-siveness to islet xenograft by MMC treatment of graft and block-age of LFA-l/'lCAM-l pathway. Transplantation (in press)
32. Bach FH. Voynovv NK (1966) One-way stimulation in mixed leukocyte cultures. Science 153:545-547
33. Malinowski K, Pullis C, Raisbeck AP, Rapaport FT (1992) Modulation of human lymphocyte marker expression by gamma irradiation and mitomycin C. Cell Immunol 143:368-377